Identification and assessment of novel degradants in pazopanib hydrochloride using stability-indicating RP-HPLC method

Pazopanib, a multi-targeted tyrosine kinase inhibitor, is used in cancer treatment. This study developed and validated an RP-HPLC method for assessing Pazopanib stability, identifying impurities and characterizing degradants from forced degradation studies of tablet forms. Using a YMC Triart C18 col...

Full description

Saved in:
Bibliographic Details
Main Authors: Rohit Prajapati, Mehul Patel, Pritesh Desai, Charmy Kothari
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Taibah University for Science
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/16583655.2025.2487722
Tags: Add Tag
No Tags, Be the first to tag this record!